Canada markets close in 1 hour 9 minutes

Aligos Therapeutics, Inc. (ALGS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8340+0.0160 (+1.96%)
As of 02:42PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 61.90M
Enterprise Value -62.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.38
Price/Book (mrq)0.67
Enterprise Value/Revenue -4.04
Enterprise Value/EBITDA 0.74

Trading Information

Stock Price History

Beta (5Y Monthly) 2.34
52-Week Change 3-29.48%
S&P500 52-Week Change 321.08%
52 Week High 31.3800
52 Week Low 30.5390
50-Day Moving Average 30.9013
200-Day Moving Average 30.7974

Share Statistics

Avg Vol (3 month) 3401.7k
Avg Vol (10 day) 3271.63k
Shares Outstanding 572.58M
Implied Shares Outstanding 676.69M
Float 836.68M
% Held by Insiders 121.07%
% Held by Institutions 162.53%
Shares Short (Apr 15, 2024) 4657.21k
Short Ratio (Apr 15, 2024) 41.68
Short % of Float (Apr 15, 2024) 40.96%
Short % of Shares Outstanding (Apr 15, 2024) 40.87%
Shares Short (prior month Mar 15, 2024) 4365.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-942.67%

Management Effectiveness

Return on Assets (ttm)-36.63%
Return on Equity (ttm)-89.48%

Income Statement

Revenue (ttm)15.53M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)-24.20%
Gross Profit (ttm)N/A
EBITDA -85.84M
Net Income Avi to Common (ttm)-87.68M
Diluted EPS (ttm)-1.3600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)135.7M
Total Cash Per Share (mrq)1.79
Total Debt (mrq)11.14M
Total Debt/Equity (mrq)12.10%
Current Ratio (mrq)5.90
Book Value Per Share (mrq)1.23

Cash Flow Statement

Operating Cash Flow (ttm)-79M
Levered Free Cash Flow (ttm)-45.91M